NCT02296125 2026-04-21
FLAURA
AstraZeneca
Phase 3 Completed
Clinical Trials
5 trialsNCT03040973 2026-04-02
Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone
Novartis
Phase 2 Active not recruiting
NCT07477457 2026-03-17
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07458919 2026-03-09
Therapy for Advanced NSCLC With EGFR 19delins Mutation
Fuzhou General Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06675695 2026-01-30
Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records Databases
Brigham and Women's Hospital
Completed